Table 2 Participant characteristics and PPH outcomes among Ecuadorian women given PPH treatment with sublingual misoprostol (600mcg and 800mcg)*
600 mcg(n = 50) | 800 mcg(n = 163) | |
|---|---|---|
Baseline characteristics | ||
Age (yr) mean ± sd, | 23 ± 6 | 24 ± 6 |
Range | 14 – 41 | 14 – 42 |
Currently married | 39 (78.0) | 140 (85.3) |
No education | 0 (0.0) | 0 (0.0) |
Primary | 11 (22.0) | 50 (30.7) |
Secondary | 29 (58.0) | 96 (58.9) |
University or higher | 10 (20.0) | 14 (8.6) |
0 | 27 (54.0) | 65 (39.9) |
1–3 | 21 (42.0) | 86 (52.8) |
4+ | 2 (4.0) | 12 (7.3) |
Pre-delivery Hb mean ± sd, | 13.4 ± 1.4 | 13.5 ± 1.3 |
Range | 10.1 – 18.1 | 10.3 – 16.9 |
Pre–term (less than 37) | 2 (4.0) | 6 (3.7) |
Term (37·0 – 40·9) | 42 (84.0) | 137 (84.0) |
Post–term (41 or more) | 6 (12.0) | 20 (12.3) |
Multiple pregnancy | 0 (0) | 0 (0) |
Known previous PPH | 1 (2.0) | 8 (4.9) |
Delivery characteristics | ||
Labor induced/augmented | 34 (68.0) | -- |
Oxytocin given in 3rd stage of labor | 50 (100.0) | -- |
Controlled cord traction + | 45 (90.0) | 114 (69.9) |
Uterine massage + | 50 (100.0) | 131 (80.4) |
PPH outcomes | ||
Blood loss (mL) at time of treatment median (IQR) | 850 (750,1050) | 850 (750, 1000) |
Total blood loss (mL) median (IQR)+ | 1000 (850, 1200) | 1150 (950, 1400) |
Blood loss ≥500 mL post-treatment | 5 (10.0) | 29 (17.8) |
Blood loss ≥1000 mL post-treatment | 0 (0.0) | 3 (6.0) |
Post-treatment Hb median IQR ^+ | 10.8 (9.9, 11.4) | 9.9 (8.9, 11.0) |
Difference between pre/post Hb median IQR^+ | 2.6 (1.4, 4.0) | 3.5 (2.6, 4.8) |
Drop in Hb ≥ 2 g/dL ^+ | 31 (63.3) | 131 (85.6) |
Additional uterotonics + | 9 (18.0) | 12 (7.4) |
Blood transfusion | 1 (2.0) | 10 (6.1) |
Exploration under anesthesia | 9 (18.0) | 16 (9.8) |